Donated globally since 2005, Novartis' flatworm treatment Egaten wins FDA nod — and a PRV
Novartis $NVS has the fix for all your parasitic flatworm needs. The Swiss drugmaker developed a human treatment for fascioliasis in partnership with the WHO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
